THE GW INTERVIEW: Cepheid s New Chief Says Diagnostics is the Best Therapy for Potential Biotech Blues | GenomeWeb

SAN FRANCISCO, April 22 - Cepheid's new CEO, John Bishop, started his job last Monday.

He is currently commuting between his home in Chicago and Cepheid's Sunnyvale, Calif., headquarters. While he is in sticker shock from shopping for a house in Silicon Valley, Bishop seems very much at home in what he sees as his role to build Cepheid from a tool concern into a "patient disease-management" company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.